Actinium Pharmaceuticals ... (ATNM)
AMEX: ATNM
· Real-Time Price · USD
1.51
-0.04 (-2.58%)
At close: May 13, 2025, 9:51 AM
Actinium Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2023 |
|---|---|
| Other Revenue Member Revenue | 81K |
| Other Revenue Member Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.69M | 2.83M | 3.59M | 2.96M | 2.31M | 2.73M | 4.56M | 3.73M | 3.96M | 3.07M | 3.23M | 1.74M | 2.65M | 1.99M | 1.71M | 1.72M | 1.8M | 1.82M | 1.15M | 1.53M | 1.26M | 1.82M | 1.08M | 1.36M | 1.32M | 1.96M | 1.57M | 1.88M | 1.34M | 1.73M | 2.81M | 3.28M | 2.9M | 1.39M | 2.75M | 2.22M | 2.31M | 1.79M | 3.55M | 3.81M |
| Selling, General, and Administrative Revenue Growth | -4.70% | -21.32% | +21.30% | +28.45% | -15.50% | -40.17% | +22.12% | -5.63% | +28.80% | -4.95% | +86.34% | -34.65% | +33.15% | +16.61% | -0.47% | -4.34% | -1.59% | +58.15% | -24.67% | +21.61% | -30.87% | +69.30% | -21.01% | +3.54% | -32.93% | +24.63% | -16.18% | +40.35% | -22.47% | -38.56% | -14.34% | +12.93% | +108.24% | -49.28% | +23.98% | -4.08% | +28.86% | -49.44% | -6.73% | n/a |
| Research and Development Revenue | 4.61M | 9.77M | 8.82M | 6.42M | 7.92M | 11.62M | 11.08M | 7.85M | 7.33M | 6.77M | 4.66M | 4.37M | 5.42M | 4.71M | 3.63M | 4.28M | 4.64M | 3.79M | 3.51M | 4.15M | 3.37M | 4.83M | 4.01M | 4.34M | 5.09M | 4.22M | 3.33M | 4.46M | 3.86M | 4.96M | 4.38M | 4.5M | 3.9M | 5.69M | 4.15M | 3.77M | 2.6M | 2.83M | 3.84M | 4.05M |
| Research and Development Revenue Growth | -52.86% | +10.75% | +37.48% | -18.94% | -31.86% | +4.88% | +41.18% | +7.04% | +8.30% | +45.24% | +6.71% | -19.33% | +15.04% | +29.66% | -15.08% | -7.82% | +22.47% | +7.98% | -15.49% | +23.04% | -30.15% | +20.45% | -7.53% | -14.73% | +20.47% | +26.95% | -25.49% | +15.66% | -22.17% | +13.21% | -2.78% | +15.43% | -31.37% | +37.07% | +10.16% | +44.99% | -8.17% | -26.31% | -5.21% | n/a |